Diffuse Gonococcal Infection (DGI) in a Patient with Treatment-Refractory Acetylcholine Receptor Antibody-Positive (AChR+) Generalized Myasthenia Gravis (gMG) Treated with Eculizumab

Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due to impaired opsonophagocytic activity. Impaired complement immunity may increase the risk for dissemination of asymptomatic Neisseria gonorrhoeae. Disseminated Gonoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Katyal, Nakul, Nirola, Latika, Narula, Naureen, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216817/
https://www.ncbi.nlm.nih.gov/pubmed/34234969
http://dx.doi.org/10.1155/2021/9713413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216817/
https://www.ncbi.nlm.nih.gov/pubmed/34234969
http://dx.doi.org/10.1155/2021/9713413

Ejemplares similares